◆ 会议时间：2019年9月25-29目
◆ 会议地点：美国 旧金山（San Francisco）
◆ 下届会议：2020年美国经导管心血管治疗研讨会/年会(TCT2020)
◆ 会议简介：
美国经导管心血管治疗学术会议（TCT）是CRF主办的世界上规模最大、最重要的专注于心血管介入医学的教育会议。30年来，TCT通过提供前沿的教育内容、展示当前治疗和临床研究的最新进展，来提高目标受众群体的能力实践。TCT科学研讨会的与会者包括：介入心脏病专家、放射科医师、临床心脏病专家、科学家，血管医学专家、心脏和血管外科医生、护士、导管室技师和其他介入和血管医学领域的相关人士等。2018年TCT科学研讨会预计有来自全球100多个国家的10000余名专业人士参会。
美国心血管研究基金会(CRF)成立于1991年，是一个致力于改善世界各地心脏病患者生存和生活质量的非营利组织。CRF在介入心血管医学中安全地使用新技术、药物等手段治疗心脏与血管疾病方面发挥了重要的作用。CRF教育中心每年举办超过50个教育会议和大会，包括年度经导管心血管治疗（TCT）科学研讨会，为相关人员提供前沿技术和创新等方面的培训(未经本站许可，禁止复制摘录镜像本站任何内容-领域国际医学会议网)。
Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For 30 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. We hope that our longstanding commitment to lifesaving innovation translates into improved patient care.
摘要提交：
ABSTRACTS
Submission Opens: Tuesday, March 5, 2019
Submission Deadline: Tuesday, June 4, 2019 (2:00 PM, ET)
Abstract submissions should address an area of interventional cardiology, endovascular medicine, or structural heart disease and constitute original research, but may include portions of prior abstracts and/or manuscripts presented elsewhere. Clinical studies, basic science investigation, and preclinical studies are equally encouraged. Reports of a single patient should be submitted to Challenging Cases, regardless of the novelty of the individual case.
LATE-BREAKING CLINICAL TRIALS AND SCIENCE
Submission Opens: Tuesday, February 26, 2019
Submission Deadline: Monday, July 8, 2019 (2:00 PM, ET)
Late-Breaking Clinical Trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials or of large-scale, impactful single-center or multicenter registries.
Late-Breaking Clinical Science submissions are the first worldwide presentations of smaller randomized trials, impactful single-center or multicenter registries, or first-in-man experiences with novel devices or drugs. Accepted submissions will be presented in the Main Arena at TCT 2019, and during press conferences scheduled on the same days as the Main Arena presentations.
The following rarely qualify as Late-Breaking Clinical Trial submissions: preclinical studies, early first-in-human device studies, and meta-analyses; these should be submitted as Abstracts or as Interventional Innovations.
CALL FOR FASCINATING LECTURES
Submission Opens: Monday, March 4, 2019
Submission Deadline: Tuesday, May 14, 2019 (2:00 PM, ET)
TCT is always looking to present fascinating and futuristic concepts and ideas that relate to improving outcomes for patients with cardiovascular disease.
Submit your ideas for an interesting lecture you would like to present that is not typical for large CV congresses.
Examples might include: digital health, machine learning, artificial intelligence, micro-imaging breakthroughs, regionalized systems of care, nano-technologies, regulatory reform, role of social media, fetal therapies for prevention, etc. Anything novel will be considered!
CHALLENGING CASES
Submission Opens: Tuesday, April 2, 2019
Submission Deadline: Thursday, June 20, 2019 (2:00 PM, ET)
Physicians from around the world are invited to submit their most challenging coronary, endovascular, and structural heart disease cases. The directors of TCT review each submitted case and select the best for presentation.
TCT 2019 注册费：
TCT Full Conference |
Early Registration
Thursday, May 30, 2019
(11:59 PM ET) |
Advance Registration
Friday, May 31 (12:00 AM ET)
to Tuesday, August 6, 2019
(11:59 PM ET) |
On-site Registration
Wednesday, August 7, 2019 (12:00 AM ET) and Onward |
| Physician |
$995.00 |
$995.00 |
$1,695.00 |
| US Fellow++ |
$0 |
$0 |
$0 |
| International Fellow++ |
$0 |
$0 |
$0 |
| Allied Health Professional |
$300.00 |
$300.00 |
$400.00 |
| Industry Professional |
$1,699.00 |
$1,799.00 |
$1,949.00 |
| US Government Official+ |
$160.00 |
$199.00 |
$229.00 |
◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|
